Eisai Co Ltd (4523.T)
4523.T on Tokyo Stock Exchange
4,295JPY
2 Aug 2013
4,295JPY
2 Aug 2013
Price Change (% chg)
¥130 (+3.12%)
¥130 (+3.12%)
Prev Close
¥4,230
¥4,230
Open
¥4,190
¥4,190
Day's High
¥4,295
¥4,295
Day's Low
¥4,130
¥4,130
Volume
1,117,800
1,117,800
Avg. Vol
1,335,844
1,335,844
52-wk High
¥4,675
¥4,675
52-wk Low
¥3,330
¥3,330
About
Eisai Co., Ltd. is mainly engaged in the manufacture and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of drugs for pharmaceutical, over-the-counter and diagnostic uses. The Others segment manufactures and... (more)
Overall
| Beta: | 0.59 |
| Market Cap (Mil.): | ¥1,235,201.00 |
| Shares Outstanding (Mil.): | 296.57 |
| Dividend: | 70.00 |
| Yield (%): | 3.60 |
Financials
| 4523.T | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 25.93 | 38.06 | 37.87 |
| EPS (TTM): | 160.61 | -- | -- |
| ROI: | 6.33 | 19.42 | 18.70 |
| ROE: | 10.56 | 20.10 | 19.53 |
Japan's Eisai pulls drug from Germany after pricing row
LONDON - Japanese drugmaker Eisai is to stop selling its new epilepsy therapy Fycompa in Germany - the biggest market for the product - following a row over the price it can charge for the drug.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Validea
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

